Chronic postsurgical pain following breast reconstruction: a commentary and critique Randy S. Roth Review 30 January 2018 Pages: 209 - 216
Rapid review: radiomics and breast cancer Francesca ValdoraNehmat HoussamiAlberto Stefano Tagliafico Review 02 February 2018 Pages: 217 - 229
The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence Sara JanssonKristina AaltonenLisa Rydén Preclinical study Open access 29 January 2018 Pages: 231 - 241
Machine learning to parse breast pathology reports in Chinese Rong TangLizhi OuyangKevin Hughes Preclinical study 29 January 2018 Pages: 243 - 250
Lymph drainage of the upper limb and mammary region to the axilla: anatomical study in stillborns Guilherme de Arruda CuadradoMauro Figueiredo Carvalho de AndradeAlfredo Luiz Jacomo Preclinical study 29 January 2018 Pages: 251 - 256
A retrospective prognostic evaluation analysis using the 8th edition of the American Joint Committee on Cancer staging system for breast cancer Sae Byul LeeGuiyun SohnSei-Hyun Ahn Preclinical study Open access 31 January 2018 Pages: 257 - 266
Systematical analysis of lncRNA–mRNA competing endogenous RNA network in breast cancer subtypes Shunheng ZhouLihong WangWei Jiang Preclinical study 01 February 2018 Pages: 267 - 275
Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy Nouf Al-SubhiReem AliSrinivasan Madhusudan Preclinical study Open access 02 February 2018 Pages: 277 - 286
Morbidity of local therapy for locally advanced metastatic breast cancer: an analysis of the Surveillance, Epidemiology, and End Results (SEER)–Medicare Registry Mark FairweatherWei JiangFaina Nakhlis Clinical trial 27 January 2018 Pages: 287 - 293
Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma Anne-Sophie HamyGiang-Thanh LamFabien Reyal Clinical study 27 January 2018 Pages: 295 - 304
A high-risk 70-gene signature is not associated with the detection of tumor cell dissemination to the bone marrow Vincent P. WalterFlorin-Andrei TaranAndreas D. Hartkopf Clinical trial 27 January 2018 Pages: 305 - 309
Tamoxifen therapy improves overall survival in luminal A subtype of ductal carcinoma in situ: a study based on nationwide Korean Breast Cancer Registry database Ki-Tae HwangEun-Kyu KimKorean Breast Cancer Society Clinical trial 30 January 2018 Pages: 311 - 322
The frequency of missed breast cancers in women participating in a high-risk MRI screening program S. VreemannA. Gubern-MeridaR. M. Mann Clinical trial Open access 31 January 2018 Pages: 323 - 331
Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I–III HER2-positive breast cancer Julia FoldiSarah MougalianLajos Pusztai Clinical trial 02 February 2018 Pages: 333 - 340
Cross-reactivity between MUC1 antigen and MCA: false elevation of serum CA 15-3 level in pregnant and lactating women by Ma695–Ma552-based assay Guangshu LiangXuqian FangZhidong Gu Clinical trial 02 February 2018 Pages: 341 - 347
Complications following immediate compared to delayed deep inferior epigastric artery perforator flap breast reconstructions J. BeugelsL. BodR. R. W. J. van der Hulst Clinical trial Open access 05 February 2018 Pages: 349 - 357
Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies E. RakovitchR. GrayL. J. Solin Epidemiology Open access 31 January 2018 Pages: 359 - 369
A comprehensive tool for measuring mammographic density changes over time Mikael ErikssonJingmei LiPer Hall Epidemiology Open access 01 February 2018 Pages: 371 - 379
A novel patient-derived xenograft model for claudin-low triple-negative breast cancer Margarite D. MatossianHope E. BurksBridgette M. Collins-Burow Brief Report 01 February 2018 Pages: 381 - 390
Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experience Nicholas B. FiguraWendy LongKamran A. Ahmed Brief Report 01 February 2018 Pages: 391 - 396